Drug Shortage Report for MAR-MONTELUKAST
Report ID | 136415 |
Drug Identification Number | 02399873 |
Brand name | MAR-MONTELUKAST |
Common or Proper name | MONTELUKAST |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | DORMANT |
Active Ingredient(s) | MONTELUKAST |
Strength(s) | 5MG |
Dosage form(s) | TABLET (CHEWABLE) TABLET (CHEWABLE) |
Route of administration | ORAL ORAL |
Packaging size | 30 Tablets |
ATC code | R03DC |
ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-03-30 |
Actual start date | 2021-03-30 |
Estimated end date | 2022-09-26 |
Actual end date | 2022-07-06 |
Shortage status | Resolved |
Updated date | 2023-07-13 |
Company comments | Business reasons |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-07-13 | French | Compare |
v6 | 2023-07-13 | English | Compare |
v5 | 2021-09-27 | French | Compare |
v4 | 2021-09-27 | English | Compare |
v3 | 2021-03-31 | English | Compare |
v2 | 2021-03-26 | French | Compare |
v1 | 2021-03-26 | English | Compare |
Showing 1 to 7 of 7